Ecron AcuNova appoints Dr Antal K Hajos

Ecron AcuNova appoints Dr Antal K Hajos

Ecron AcuNova, the full service CRO with over two decades of track record, appointed Dr Antal K Hajos as Executive Vice President–Strategic Operations for the European region. In this role, Dr Hajos will focus on leveraging the opportunities of the company’s European as well as Indian capabilities to optimise service level and operational benefits for its clients. He will be based at Ecron AcuNova’s European headquarter in Frankfurt, Germany. With over 15 years’ experience, Dr Hajos brings with him substantial experience in clinical research and drug development from a number of positions in the pharmaceutical industry. Prior to joining Ecron AcuNova, he was the Managing Director and Chair of the Board with Nycomed Pharma’s Indian R&D centre based at Mumbai, and was also responsible for Altana Pharma’s global clinical operations. 

Speaking on the appointment, Dr Klaus Wiedey, President and CEO, Ecron AcuNova, said, “This appointment underlines Ecron AcuNova’s commitment to the European and Indian market, where the company is rapidly expanding its client base, operations and expertise.  Dr Hajos’ extensive industry experience across the globe, his proven ability to provide superior value to clients and leadership in the domain of clinical development will be invaluable. We are looking forward to growing together and redefining innovation in the clinical research space.”